MORC2 Antibody

Product Specs
ItemMORC2 Antibody - BSA Free
CompanyNovus Biologicals, a Bio-Techne Brand
Price $539.00Supplier Page View Company Product Page
Catalog NumberNBP1-89295
TargetMORC2
HostRabbit
ReactivityHuman,Mouse
Quantity0.1 ml (also 25ul)
Conjugate/TagUnconjugated
FormatPBS (pH 7.2) and 40% Glycerol
ImmunogenThis antibody was developed against Recombinant Protein corresponding to amino acids: TSECLRIEPD TTALSTNHET IDLLVQILRN CLRYFLPPSF PISKKQLSAM NSDELISFPL KEYFKQYEVG LQNLCNSYQS RADSRAKASE ESLRTSERKL RETEEKLQKL RTNIVALLQK VQEDIDINTD DELDAYIED
ApplicationsIF/IHC,Immunohistochemistry,Immunohistochemistry-Paraffin,Immunocytochemistry/ Immunofluorescence
IsotypeIgG
ClonalityPolyclonal
PurityAffinity purified
Research AreaTranscription Factors and Regulators
Antibody TypePrimary Antibodies
StorageStore at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles
NCBI Full Gene NameMORC family CW-type zinc finger 2
NCBI Gene AliasesCMT2Z, DIGFAN, ZCW3, ZCWCC1

Sequence

TSECLRIEPDTTALSTNHETIDLLVQILRNCLRYFLPPSFPISKKQLSAMNSDELISFPLKEYFKQYEVGLQNLCNSYQSRADSRAKASEESLRTSERKLRETEEKLQKLRTNIVALLQKVQEDIDINTDDELDAYIED

Specifications/Features

Available conjugates: Available conjugates: Unconjugated

Sizes Available: 0.1 ml (also 25ul)

Add to Compare List

Novus Biologicals, a Bio-Techne Brand

United States: 10771 E Easter Ave

Centennial, Colorado 80112

United States

Phone:
303-730-1950
888-506-6887

Email: novus@novusbio.com

Company Profile

Website: https://www.novusbio.com

(1) HSP90 N-terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2-driven breast cancer progressionClinical and translational medicineJanuary 1, 0001"Yang F, Sun R, Hou Z, Zhang FL, Xiao Y, Yang YS, Yang SY, Xie YF, Liu YY, Luo C, et al."with 10% formalin and then subjected to immunohistochemical (IHC) staining with an anti‐MORC2 (Novus, NBP1‐89295, 1:50) or anti‐cyclin D1 (Cell Signaling Technology, #2978S, 1:150) antibody. Olympus BX43 microscope

(2) High expression of MORC2 predicts worse neoadjuvant chemotherapy efficacy in triple negative breast cancerMedicineJanuary 1, 0001"Liao X, Liu C, Ding Z, Wang C, He J, Wu S."CA) following the manufacturer’s recommendations. The primary antibody against human MORC2 (Novus, #NBP1-89295) was diluted at dilution of 1:100 and then incubated at 4°C overnight in a humidified container. Positive

(3) O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progressionCell death and differentiationJanuary 1, 0001"Liu YY, Liu HY, Yu TJ, Lu Q, Zhang FL, Liu GY, Shao ZM, Li DQ."anti-OGT (Proteintech, #11576, 1:200), anti-O-GlcNAc (ThermoFisher, #MA1–072, 1: 200), anti-MORC2 (Novus, #NBP1–89295, 1:150), anti-SNAIL (Abcam, # ab224731, 1:200) or anti-CTGF (Proteintech, #23936-1-AP, 1:200) antibody.

(4) Association of MORC2 expression with progression-free survival in cervical cancer patients treated with concurrent chemoradiotherapyMedicineJanuary 1, 0001"He J, Liao XH, Zhong BD, Liu AW."Clara) following the manufacturer’s recommendations. The primary antibody against human MORC2 (Novus, #NBP1-89295) was diluted at dilution of 1:100 and then incubated at 4°C overnight in a humidified container. Positive

Be the First to Write a Review!

MORC2 Antibody

MORC2 Antibody

MORC2 Antibody

MORC2 Antibody

MORC2 Antibody - BSA Free from Novus Biologicals, a Bio-Techne Brand

Sequence

Specifications/Features

Novus Biologicals, a Bio-Techne Brand

Citations (4)

Reviews

MORC2 Antibody - BSA Free from Novus Biologicals, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map